Simon Cavallo has been making headlines for several years in the field of weight loss through a psychological approach. His programs, focused on mental reprogramming rather than a traditional diet, provoke polarized reactions on forums and social media.
By mid-2026, the context has changed: new regulated medical treatments are entering the French market, and consumer expectations are evolving. The question of the reliability of online reviews regarding him deserves to be addressed with concrete elements.
See also : Why try the fury room in Lyon in 2026 to release your frustrations?
Anti-obesity treatments reimbursed in France: a context that redefines comparison
Most articles analyzing reviews on Simon Cavallo merely contrast positive and negative opinions, without considering the medical environment in which these programs now exist. Since June 15, 2026, Wegovy and Mounjaro are reimbursed at 65% by Health Insurance for patients meeting severe obesity criteria, after failing nutritional management.
This development changes the game. People with obesity and comorbidities now have a regulated medical alternative, prescribed by a doctor, with clinical follow-up. Simon Cavallo’s programs, on the other hand, fall under non-medical coaching, without reimbursement or formal medical supervision.
Read also : Everything You Need to Know About Free Mobile Billing in 2026: New Features and Practical Tips
When reading the reviews on Simon Cavallo published before this date, they do not take this new option into account. A review written in 2024 or 2025 by a user who did not have access to these treatments does not carry the same weight as a review written after June 2026. The consumer’s perspective has mechanically shifted.
Online reviews on Simon Cavallo: what the structure of the reviews reveals
Feedback on Simon Cavallo’s programs follows a recurring pattern. Positive reviews mention a psychological breakthrough, an awareness of the relationship with food, and sometimes weight loss in the first weeks. Negative reviews point to content perceived as insufficient relative to the price, unsustainable results, or a feeling of exaggerated promises.
The issue lies not so much in the sincerity of these testimonials but in their publication context. Several points deserve attention:
- Review platforms do not verify whether the author has actually completed the full program or if they abandoned it after a few days
- Positive testimonials highlighted on sales pages are selected by the seller, without transparent methodology
- Negative reviews on forums are sometimes written in a moment of frustration, lacking long-term perspective
- No independent organization has published a standardized evaluation of these programs in 2026
The absence of an independent evaluation protocol makes it difficult to draw any firm conclusions. Field feedback diverges on this point, and neither supporters nor detractors have clinical data to support their position.
Mental reprogramming and weight loss: what scientific literature allows us to say
Simon Cavallo relies on the concept of mental reprogramming, a marketing term that encompasses techniques borrowed from hypnosis, NLP, and cognitive-behavioral therapies. The term itself does not have a fixed scientific definition.
Cognitive-behavioral therapies applied to eating have been researched for several decades. Their effectiveness in modifying eating behaviors is documented within a structured therapeutic framework, with a trained healthcare professional. In contrast, transposing these techniques into an online program without individual follow-up raises questions about actual effectiveness and safety.
The report from the Academy of Medicine published in June 2026 on incretin receptor agonists emphasizes the importance of medical supervision in the management of obesity. This document does not mention mental coaching programs, but it establishes a clear framework: sustainable weight loss requires structured follow-up tailored to the patient’s profile.
Placebo effect and user expectations
Several competing articles mention a possible placebo effect related to adherence to the program. The hypothesis is plausible. The belief that one has found a solution can, in the short term, modify eating behaviors. The available data does not allow us to conclude whether the results observed by some users stem from a lasting change or a temporary effect related to initial motivation.
Business model and marketing: signals to interpret
Simon Cavallo’s business model relies on selling digital programs, often through sales funnels with webinars, email sequences, and limited-time offers. This type of funnel is common in the online coaching sector and does not in itself constitute a negative signal.
What raises questions is the gap between marketing promises and the evidence framework. When a program promises weight loss “without diet, without exercise, without effort,” it creates an expectation that reality often struggles to meet. The most substantiated negative reviews specifically point out this gap.
Another element to consider: the price of the programs is not always clearly displayed before signing up for the webinar. This pricing opacity, reported by several dissatisfied users, fuels distrust. In a context where reimbursed medical treatments now exist, the question of value for money arises with greater acuity.
Absence of certification or quality label
Simon Cavallo does not claim any title as a healthcare professional. His programs are not backed by any recognized certification in the medical or paramedical field. This transparency about his non-medical status is a positive point. It also implies that the consumer assumes full responsibility for their choice, without a regulatory safety net comparable to that of a medical consultation.
The reliability of reviews on Simon Cavallo in 2026 largely depends on when they were written and the profile of their authors. The arrival of reimbursed anti-obesity treatments redefines the landscape in which these programs exist. Reading a review without checking its date, publication context, and the absence of medical follow-up amounts to making a decision on incomplete grounds.